Acadia Healthcare posts Q3 2026 results and lifts full‑year revenue and earnings guidance

Acadia Healthcare reported third‑quarter 2026 revenue of $895.3 million, a 5.1% year‑over‑year increase, and adjusted EBITDA of $176.4 million. Net income fell to $34.5 million, yielding reported EPS of $0.38 and adjusted EPS of $0.60. The company raised its full‑year 2026 revenue outlook to $3.44‑$3.46 billion and adjusted EPS guidance to $1.70‑$1.80 per share, while lowering its capital‑expenditure forecast to $210‑$230 million.

The higher revenue and EPS guidance suggests stronger earnings potential for the rest of 2026, which could support the stock’s price. The reduced cap‑ex outlook may improve cash‑flow generation and leverage metrics for investors.

  • 1Revenue totaled $895.3 million, up 5.1% YoY.
  • 2Adjusted EBITDA was $176.4 million, a 2% increase from the prior year.
  • 3Net income attributable to Acadia was $34.5 million, or $0.38 per diluted share.
  • 4Adjusted EPS was $0.60 per diluted share, down from $0.72 a year earlier.
  • 5Full‑year 2026 revenue guidance raised to $3.44‑$3.46 billion.
  • 6Full‑year 2026 adjusted EPS guidance raised to $1.70‑$1.80 per share.

Sources